CG Invites Co., Ltd. (KOSDAQ:083790)
South Korea · Delayed Price · Currency is KRW 917.00
+17.00 (1.89%)
Aug 12, 2026, 1:05 PM KST
CG Invites Market Cap
CG Invites has a market cap or net worth of 69.2 billion as of August 11, 2026. Its market cap has decreased by -48.57% in one year.
Market Cap
69.20B
Enterprise Value
120.89B
Revenue
29.22B
Ranking
n/a
PE Ratio
n/a
Stock Price
917.00
ChartMarket Cap Chart
Since January 6, 2006, CG Invites's market cap has decreased from 137.39B to 69.20B, a decrease of -49.63%. That is a compound annual growth rate of -3.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 69.20B | -39.48% |
| Dec 30, 2025 | 114.34B | -38.17% |
| Dec 30, 2024 | 184.93B | -11.21% |
| Dec 28, 2023 | 208.28B | -13.64% |
| Dec 29, 2022 | 241.17B | -46.50% |
| Dec 30, 2021 | 450.79B | -45.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genexine | 120.07B |
| Vaxcell-Bio Therapeutics | 96.98B |
| MedPacto | 94.94B |
| iNtRON Biotechnology | 80.78B |
| Prestige BioPharma | 79.33B |
| Amicogen | 72.14B |
| ENCell | 68.05B |
| ORIENT BIO | 63.14B |